These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18342230)

  • 1. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
    Ibanez B; Vilahur G; Cimmino G; Speidl WS; Pinero A; Choi BG; Zafar MU; Santos-Gallego CG; Krause B; Badimon L; Fuster V; Badimon JJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1104-9. PubMed ID: 18342230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging.
    Parolini C; Marchesi M; Lorenzon P; Castano M; Balconi E; Miragoli L; Chaabane L; Morisetti A; Lorusso V; Martin BJ; Bisgaier CL; Krause B; Newton RS; Sirtori CR; Chiesa G
    J Am Coll Cardiol; 2008 Mar; 51(11):1098-103. PubMed ID: 18342229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
    Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
    Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging.
    Zhao XQ; Brown BG
    J Am Coll Cardiol; 2008 Mar; 51(11):1110-1. PubMed ID: 18342231
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?
    Tardif JC
    J Clin Lipidol; 2010; 4(5):399-404. PubMed ID: 21122683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex.
    Kaul S; Coin B; Hedayiti A; Yano J; Cercek B; Chyu KY; Shah PK
    J Am Coll Cardiol; 2004 Sep; 44(6):1311-9. PubMed ID: 15364338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study.
    Viles-Gonzalez JF; Fuster V; Corti R; Valdiviezo C; Hutter R; Corda S; Anand SX; Badimon JJ
    Eur Heart J; 2005 Aug; 26(15):1557-61. PubMed ID: 15734766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.
    Giannarelli C; Cimmino G; Connolly TM; Ibanez B; Ruiz JM; Alique M; Zafar MU; Fuster V; Feuerstein G; Badimon JJ
    Eur Heart J; 2012 Jan; 33(2):264-73. PubMed ID: 21606082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.
    Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B
    Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic plaque imaging and monitoring atherosclerotic plaque interventions.
    Momiyama Y; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):349-55. PubMed ID: 18025989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
    Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation.
    Guo ZJ; Hou FF; Liu SX; Tian JW; Zhang WR; Xie D; Zhou ZM; Liu ZQ; Zhang X
    Int J Cardiol; 2009 Aug; 136(3):315-24. PubMed ID: 19178960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
    Nissen SE; Tsunoda T; Tuzcu EM; Schoenhagen P; Cooper CJ; Yasin M; Eaton GM; Lauer MA; Sheldon WS; Grines CL; Halpern S; Crowe T; Blankenship JC; Kerensky R
    JAMA; 2003 Nov; 290(17):2292-300. PubMed ID: 14600188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing an animal model of unstable atherosclerotic plaques.
    Chen WQ; Zhang Y; Zhang M; Ji XP; Yin Y; Zhu YF
    Chin Med J (Engl); 2004 Sep; 117(9):1293-8. PubMed ID: 15377416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
    Nicholls SJ; Cutri B; Worthley SG; Kee P; Rye KA; Bao S; Barter PJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2416-21. PubMed ID: 16141405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.